{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:40:15Z","timestamp":1711712415055},"reference-count":38,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1254\/jphs.09r28fm","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T05:20:17Z","timestamp":1281590417000},"page":"17-24","source":"Crossref","is-referenced-by-count":7,"title":["Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Regulation of Dopaminergic Neural Transmission by Tyrosine Hydroxylase Protein at Nerve Terminals"],"prefix":"10.1254","volume":"114","author":[{"given":"Chiho","family":"Sumi-Ichinose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Ikemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunao","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3470001"},{"issue":"34","key":"2","doi-asserted-by":"crossref","first-page":"20496","DOI":"10.1016\/S0021-9258(19)47089-0","volume":"264","year":"1989","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/336385a0"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/ni1001-907"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.602532"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9220"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Longo N. Disorders of biopterin metabolism. J Inherit Metab Dis. 2009;32:333–342.","DOI":"10.1007\/s10545-009-1067-2"},{"key":"8","unstructured":"8 Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. In: Advances in neurology. Eldridge R, Farn S, editors, Vol. 14, New York: Raven Press; 1976. p. 215–233."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1038\/ng1194-236"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 1999;53:1032–1041.","DOI":"10.1212\/WNL.53.5.1032"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Blau N, Thöny B, Heizmann CW, Dhondt JL. Tetrahydrobiopterin deficiency: From phenotype to genotype. Pteridines. 1993;4:1–10.","DOI":"10.1515\/pteridines.1993.4.1.1"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M102237200"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303986200"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03402.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Mercer EH, Hoyle GW, Kapur RP, Brinster RL, Palmiter RD. The dopamine beta-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron. 1991;7:703–716.","DOI":"10.1016\/0896-6273(91)90274-4"},{"issue":"47","key":"16","doi-asserted-by":"crossref","first-page":"29725","DOI":"10.1016\/S0021-9258(18)43941-5","volume":"269","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806065105"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Shashidharan P, Sandu D, Potla U, Armata IA, Walker RH, McNaught KS, et al. Transgenic mouse model of early-onset DYT1 dystonia. Hum Mol Genet. 2005;14:125–133.","DOI":"10.1093\/hmg\/ddi012"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 2000;23:S71–S77.","DOI":"10.1016\/S1471-1931(00)00027-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Canales JJ, Graybiel AM. A measure of striatal function predicts motor stereotypy. Nat Neurosci. 2000;3:377–383.","DOI":"10.1038\/73949"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05423.x"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb02098.x"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvj073"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)80230-G"},{"issue":"2","key":"25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1471-4159.1996.67020752.x","volume":"67","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Brand MP, Heales SJR, Land JM, Clark JB. Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J Inher Metab Dis. 1995;18:33–39.","DOI":"10.1007\/BF00711370"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1086\/501372"},{"issue":"4","key":"28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2008.01.028","volume":"367","author":"TAKAZAWA CHISATO","year":"2008","ISSN":"http:\/\/id.crossref.org\/issn\/0006-291X","issn-type":"print"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.40.24534"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10109"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Zorzi G, Thöny B, Blau N. Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem. 2002;80:326–364.","DOI":"10.1046\/j.0022-3042.2001.00710.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hawkins RA, O’Kane RL, Simpson IA, Viña JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136:218S–226S.","DOI":"10.1093\/jn\/136.1.218S"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Ogawa S, Ichinose H. Effect of metals and phenylalanine on the activity of human tryptophan hydroxylase-2: Comparison with that on tyrosine hydroxylase activity. Neurosci Lett. 2005;401:261–265.","DOI":"10.1016\/j.neulet.2006.03.031"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Graybiel AM, Ohta K, Roffler-Tarlov S. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J Neurosci. 1990;10:720–733.","DOI":"10.1523\/JNEUROSCI.10-03-00720.1990"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Hornykiewicz O. Striatal dopamine in dopa-responsive dystonia: comparison with idiopathic Parinson’s disease and other dopamine-dependent disorders. In: Segawa M, Nomura Y, editors. Monogr neural science. Basel: Karger; 1995. p. 101–108.","DOI":"10.1159\/000423595"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med. 1988;318:876–880.","DOI":"10.1056\/NEJM198804073181402"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Hamasaki T, Goto S, Nishikawa S, Ushio Y. Neuronal cell migration for the developmental formation of the mammalian striatum. Brain Res Brain Res Rev. 2003;41:1–12.","DOI":"10.1016\/S0165-0173(02)00216-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Kim DS, Froelick GJ, Palmiter RD. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J Neurosci. 2002;22:9841–9849.","DOI":"10.1523\/JNEUROSCI.22-22-09841.2002"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T11:02:15Z","timestamp":1711710135000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/114\/1\/114_09R28FM\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09r28fm","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}